Received Jun 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient that received their First dose in JAN-2025 / Second Late Dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 41-year-old female patient who did not receive HAB (Twinrix) suspension for injection in pre-filled syringe for prophylaxis. Previously administered products included Twinrix (received the first dose in JAN-2025). The patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: patient that received their First dose in JAN-2025 / Second Late Dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 01-JUN-2026 The batch number was not provided and a request for this information has been made.